Evidence map›Paper›PMID 34140166›Full record

ReviewMedicina clinica2021

Medical sequels of COVID-19.

Francisco Pablo Peramo-Álvarez, Miguel Ángel López-Zúñiga, Miguel Ángel López-Ruz

Abstract readReview
In one paragraph

Review in Medicina clinica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Post-COVID-19 cardiological alterations.Sao Paulo medical journal = Revista paulista de medicina · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francisco Pablo Peramo-ÁlvarezFacultad de Medicina, Universidad de Granada, Granada, España.
Miguel Ángel López-ZúñigaInfectious Diseases Unit, Hospital Universitario Virgen de las Nieves, Granada, España. Electronic address: miguelangellopezzuniga@gmail.com.
Miguel Ángel López-RuzInfectious Diseases Unit, Hospital Universitario Virgen de las Nieves, Granada, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 pandemic has impacted the world population, with a high rate of morbidity and mortality. While the evidence to date has attempted to describe clinical feature of acute illness, recent reports have also begun to describe persistent symptoms that extend beyond the initial period of illness. Adverse outcomes, in addition to respiratory, have been found to occur at different levels: cardiovascular, neurological, or immunological; skin, gastrointestinal or renal manifestations. The detrimental effect on mental health has also been described, not only in COVID-19 patients. The burden of disease secondary to this pandemic is likely to be enormous and not limited to acute disease alone, thus epidemiological studies are needed to further investigate the long-term impact of this disease. This review summarizes the current evidence on short-term effects and describes the possible long-term sequelae of COVID-19.

Indexed as

COVID-19PandemicsHumansSARS-CoV-2CardiologicalCardiológicasCoronavirusCOVIDCOVID-19NeurologicalNeurológicasPsiquiátricasPsychiatricRespiratoriasRespiratorySARS-CoV-2SecuelasSequelae

Identifiers

PMID34140166
PMCPMC8157124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.